Comparative Pharmacology
Head-to-head clinical analysis: HICON versus PRO BANTHINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HICON versus PRO BANTHINE.
HICON vs PRO-BANTHINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Unknown; possibly involves modulation of hypothalamic thermoregulatory center.
Propantheline is a muscarinic receptor antagonist that competitively blocks the action of acetylcholine at postganglionic parasympathetic effector sites, resulting in anticholinergic effects such as decreased gastrointestinal motility and secretion.
HICON (norepinephrine) 0.05-0.5 mcg/kg/min IV continuous infusion, titrated to blood pressure.
15 mg orally three times daily before meals and 30 mg orally at bedtime.
None Documented
None Documented
Terminal half-life: 12-18 hours; prolonged to 24-36 hours in renal impairment (CrCl <30 mL/min)
Terminal elimination half-life is approximately 9 hours (range 6-12 hours) in patients with normal renal function; prolonged in renal impairment, requiring dose adjustment.
Renal: 70% as unchanged drug; biliary/fecal: 25% as metabolites; 5% other
Renal excretion accounts for approximately 70% of elimination, with 30% as intact drug and 40% as inactive metabolites; biliary/fecal excretion contributes less than 5%.
Category C
Category C
Anticholinergic
Anticholinergic